JP2010526840A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526840A5
JP2010526840A5 JP2010507811A JP2010507811A JP2010526840A5 JP 2010526840 A5 JP2010526840 A5 JP 2010526840A5 JP 2010507811 A JP2010507811 A JP 2010507811A JP 2010507811 A JP2010507811 A JP 2010507811A JP 2010526840 A5 JP2010526840 A5 JP 2010526840A5
Authority
JP
Japan
Prior art keywords
proportions
mixtures
compound according
treatment
pharmaceutically usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526840A (ja
JP5543335B2 (ja
Filing date
Publication date
Priority claimed from DE102007022565A external-priority patent/DE102007022565A1/de
Application filed filed Critical
Publication of JP2010526840A publication Critical patent/JP2010526840A/ja
Publication of JP2010526840A5 publication Critical patent/JP2010526840A5/ja
Application granted granted Critical
Publication of JP5543335B2 publication Critical patent/JP5543335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507811A 2007-05-14 2008-04-18 複素環式インダゾール誘導体 Expired - Fee Related JP5543335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007022565A DE102007022565A1 (de) 2007-05-14 2007-05-14 Heterocyclische Indazolderivate
DE102007022565.4 2007-05-14
PCT/EP2008/003143 WO2008138448A2 (de) 2007-05-14 2008-04-18 Heterocyclische indazolderivate

Publications (3)

Publication Number Publication Date
JP2010526840A JP2010526840A (ja) 2010-08-05
JP2010526840A5 true JP2010526840A5 (OSRAM) 2011-06-02
JP5543335B2 JP5543335B2 (ja) 2014-07-09

Family

ID=39837777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507811A Expired - Fee Related JP5543335B2 (ja) 2007-05-14 2008-04-18 複素環式インダゾール誘導体

Country Status (10)

Country Link
US (1) US8334309B2 (OSRAM)
EP (1) EP2155728B1 (OSRAM)
JP (1) JP5543335B2 (OSRAM)
AR (1) AR066557A1 (OSRAM)
AU (1) AU2008250706B2 (OSRAM)
CA (1) CA2687162C (OSRAM)
DE (1) DE102007022565A1 (OSRAM)
ES (1) ES2548444T3 (OSRAM)
IL (1) IL202034A (OSRAM)
WO (1) WO2008138448A2 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012135631A1 (en) 2011-03-30 2012-10-04 Arrien Pharmaeuticals Llc Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
WO2012173099A1 (ja) * 2011-06-14 2012-12-20 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有するアミノ誘導体
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CA2928568A1 (en) 2013-07-26 2015-01-29 Update Pharma Inc. Combinatorial methods to improve the therapeutic benefit of bisantrene
EP3262041A4 (en) * 2015-02-27 2018-08-01 Lycera Corporation Indazolyl thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
WO2018039539A1 (en) * 2016-08-26 2018-03-01 Lycera Corporation Indazolyl-l,2,4-thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
GB201801226D0 (en) 2018-01-25 2018-03-14 Redx Pharma Plc Modulators of Rho-associated protein kinase
WO2021043966A1 (en) * 2019-09-06 2021-03-11 Inflazome Limited Nlrp3 inhibitors
CN111548320B (zh) * 2019-10-09 2023-03-24 贵州大学 一类1，3，4-噁二唑酰肼类化合物及其制备方法和应用
GB202200735D0 (en) * 2022-01-20 2022-03-09 Redx Pharma Plc Compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227841A (en) 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DE19917990A1 (de) 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
DE10042137A1 (de) 2000-08-28 2002-03-14 Florian Lang sgk2 und sgk3 als diagnostische und therapeutische Targets
US7115617B2 (en) * 2001-08-22 2006-10-03 Amgen Inc. Amino-substituted pyrimidinyl derivatives and methods of use
WO2003051847A1 (en) 2001-12-19 2003-06-26 Smithkline Beecham P.L.C. (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
AU2003227741A1 (en) 2002-05-17 2003-12-02 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
FR2844267B1 (fr) 2002-09-05 2008-02-15 Aventis Pharma Sa Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
AU2003278249B8 (en) 2002-09-05 2010-11-18 Aventis Pharma S.A. Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
AU2003293376A1 (en) 2002-12-10 2004-06-30 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
FR2848554A1 (fr) 2002-12-12 2004-06-18 Aventis Pharma Sa Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
PL376789A1 (pl) 2002-12-12 2006-01-09 Aventis Pharma S.A. Pochodne aminoindazoli i ich zastosowanie jako inhibitorów kinazy
US20050019366A1 (en) 2002-12-31 2005-01-27 Zeldis Jerome B. Drug-coated stents and methods of use therefor
WO2005000813A1 (en) 2003-05-30 2005-01-06 Imclone Systems Incorporated Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
US20050090529A1 (en) 2003-07-31 2005-04-28 Pfizer Inc 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
WO2005023761A2 (en) 2003-09-11 2005-03-17 Kemia, Inc. Cytokine inhibitors
WO2005035506A1 (ja) 2003-10-15 2005-04-21 Ube Industries, Ltd. 新規インダゾール誘導体
EP2065383A1 (en) * 2003-11-19 2009-06-03 Signal Pharmaceuticals, Inc. Indazole compounds and methods of use thereof as protein kinase inhibitors
CA2546360A1 (en) 2003-11-19 2005-06-09 Signal Pharmaceuticals, Llc Methods of treating diseases and disorders by targeting multiple kinases
US7569578B2 (en) 2003-12-05 2009-08-04 Bristol-Meyers Squibb Company Heterocyclic anti-migraine agents
DE102004028862A1 (de) * 2004-06-15 2005-12-29 Merck Patent Gmbh 3-Aminoindazole
AU2005295441B2 (en) 2004-10-18 2009-04-23 Amgen, Inc. Thiadiazole compounds and methods of use
JP2008534633A (ja) * 2005-04-04 2008-08-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Ｃｈｋ１、ｃｈｋ２およびｓｇｋ阻害剤としてのインダゾールスクアリン酸誘導体
DE102007002717A1 (de) * 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclische Indazolderivate

Similar Documents

Publication Publication Date Title
JP2010526840A5 (OSRAM)
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
WO2007107470A3 (en) Pyrazoles as 11-beta-hsd-1
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
JP2004519469A5 (OSRAM)
UA110853C2 (uk) Лікарські форми інгібітора гістондеацетилази у комбінації з бендамустином та їхнє застосування
JP2012533546A5 (OSRAM)
JP2006504795A5 (OSRAM)
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
RU2012123372A (ru) Гетероциклические модуляторы транспортеров атф-связывающей кассеты
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
NO20074872L (no) Pyrazoler
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
JP2010520246A5 (OSRAM)
JP2017222722A5 (OSRAM)
JP2017522300A5 (OSRAM)
CN115605485A (zh) 大环化合物的固体形式及其制备和用途
JP2009517411A5 (OSRAM)
JP2009518415A5 (OSRAM)
CA2596145A1 (en) Prevention and treatment of thromboembolic disorders
CN114364676A (zh) 新型三环芳香杂环化合物,及其制备方法、药物组合物和应用
JP2016515550A5 (OSRAM)
JP2008501316A5 (OSRAM)